+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Retinal Imaging Devices Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 177 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5635641
The Global Retinal Imaging Devices Market is estimated to be USD 5.02 Bn in 2022 and is expected to reach USD 7.17 Bn by 2027, growing at a CAGR of 7.39%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Retinal Imaging Devices Market is segmented based on Type, End User, and Geography.
  • By Type, the market is classified into Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography (OCT).
  • By End User, the market is classified into ASCs, Hospitals, and Ophthalmic Centers.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Aimil Ltd, Apollo Medical Optics, Ltd, AQUYRE Biosciences, Argus Science, LLC, Avinger, Inc, Axsun Technologies Inc,, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Retinal Imaging Devices Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Retinal Imaging Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Retinal Imaging Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Incidence and Cases Of Ophthalmic Diseases
4.1.2 Increasing Volume of Strategic Initiatives
4.1.3 Integration of Imaging Modalities with Artificial Intelligence and the Development of Portable Devices
4.2 Restraints
4.2.1 High cost of Fundus Camera, and Optical Coherence Tomography (OCT)
4.3 Opportunities
4.3.1 Increasing Development of Launching Advanced Retinal Imaging Solutions
4.3.2 Increasing Medical Healthcare in Emerging Economies
4.4 Challenges
4.4.1 Increasing Number of Product Recalls
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Retinal Imaging Devices Market, By Type
6.1 Introduction
6.2 Fluorescein Angiography
6.3 Fundus Camera
6.4 Optical Coherence Tomography (OCT)
7 Global Retinal Imaging Devices Market, By End User
7.1 Introduction
7.2 ASCs
7.3 Hospitals
7.4 Ophthalmic Centers
8 Americas' Retinal Imaging Devices Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Retinal Imaging Devices Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Retinal Imaging Devices Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Retinal Imaging Devices Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Aimil Ltd
13.2 Apollo Medical Optics, Ltd
13.3 AQUYRE Biosciences
13.4 Argus Science, LLC
13.5 Avinger, Inc
13.6 Axsun Technologies Inc
13.7 Basler AG
13.8 BaySpec, Inc
13.9 Beye, LLC
13.10 BioMedTech LLC
13.11 Biosensors International Group
13.12 Biotex Inc
13.13 CenterVue SpA
13.14 DualAlign LLC
13.15 Epipole Ltd
13.16 Eyenuk Inc
13.17 Forus Health Pvt. Ltd
13.18 NIDEK CO., Ltd
13.19 Olympus Corp
13.20 Optomed Oy
13.21 Optos plc
13.22 Robert Bosch GmbH
13.23 Shanghai New Eyes Medical Inc
13.24 Thorlabs, Inc
13.25 Topcon Corp
13.26 ZEISS International
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Aimil Ltd
  • Apollo Medical Optics, Ltd
  • AQUYRE Biosciences
  • Argus Science, LLC
  • Avinger, Inc
  • Axsun Technologies Inc
  • Basler AG
  • BaySpec, Inc Beye, LLC
  • BioMedTech LLC
  • Biosensors International Group
  • Biotex Inc
  • CenterVue SpA
  • DualAlign LLC
  • Epipole Ltd Eyenuk Inc Forus Health Pvt. Ltd NIDEK CO., Ltd Olympus Corp Optomed Oy
  • Optos plc
  • Robert Bosch GmbH
  • Shanghai New Eyes Medical Inc
  • Thorlabs, Inc
  • Topcon Corp ZEISS International